Galenica to Cease Production at Bichsel Subsidiary, Cutting Up to 170 Jobs
Swiss pharmaceutical group Galenica has announced it will stop pharmaceutical production at its Bichsel subsidiary by the end of the year due to a lack of competitiveness. The move is expected to result in the loss of up to 170 jobs by the end of 2026.


